Univa Health, a UK-based healthtech company, has secured £1 million in pre-seed funding to revolutionise eating disorder care through AI. This funding round, led by prominent investors, marks a significant step towards redefining how such disorders are treated.
The funds will be pivotal in developing Univa’s personalised care platform. The company aims to conduct its first clinical trials in collaboration with the NHS, signalling a strong potential impact on healthcare systems and patient lives.
Launching Innovative Solutions by 2025
With the newly acquired funds, Univa Health plans to launch its innovative digital platform by early 2025. This forward-thinking platform aims to transform healthcare systems’ approach to managing and treating eating disorders. By incorporating AI, the platform will personalise treatment plans, potentially improving outcomes for countless individuals and their families.
This investment will not only fuel technological advancements but also support Univa’s first clinical study. Conducted in partnership with the NHS, this study will evaluate the platform’s efficacy, ensuring thorough testing before its widespread implementation.
Addressing a Growing Challenge
Eating disorders have seen a dramatic rise in cases, with UK hospital admissions increasing by 84% over five years. The complexity of these disorders demands more than a one-size-fits-all treatment, yet existing healthcare systems often fall short.
Chronic underfunding and a lack of specialised personnel mean that only a fraction of those affected receive adequate care. The NHS can currently cater to just 10% of adults in need, a stark indicator of the systemic challenges faced.
Univa Health, through its AI-driven approach, seeks to address these gaps by offering tailored, effective treatment, providing hope where it is most needed.
The Visionaries Behind Univa Health
Univa Health is the brainchild of Rich Andrews and Jose Santos, both seasoned entrepreneurs in the healthcare sector.
Rich Andrews previously founded Healios, expanding it to become a leading digital clinic for mental health across the UK and the US.
Jose Santos co-founded Indivi after personal experiences highlighted the need for better healthcare solutions. His work on digital biomarker platforms underscores his commitment to innovation.
Together, they aim to tackle eating disorders with a comprehensive and empathetic approach, blending technology with deep clinical insights.
Harnessing AI for Personalized Treatment
Univa’s digital tools set it apart in the healthtech landscape. The platform offers AI-driven monitoring, real-time health analytics, and bespoke therapeutic programmes, all accessible via connected apps for patients and carers.
Incorporating real-life stories from those with lived experiences, the platform enhances engagement and support for users. Clinicians can access a dedicated portal to craft and monitor treatment plans, ensuring a personalised approach.
This integration not only maximises treatment efficacy but also streamlines resource allocation, allowing healthcare professionals to focus on delivering targeted, high-quality care.
Investors’ Insight and Support
Investors have recognised Univa’s transformative potential. Reinhard Meier of YZR Capital highlights the scalable solutions Univa provides, citing the team’s experience and NHS connections as key strengths.
Calm/Storm Ventures’ Johannes Blaschke emphasises the innovation in addressing systemic healthcare issues. He believes the platform’s dual focus on patients and caregivers is critical in such a complex field.
These endorsements from leading investors reflect confidence in Univa’s ability to deliver meaningful change in the eating disorder treatment landscape.
Towards a New Horizon in Healthcare
The backing from YZR Capital and Calm/Storm Ventures marks a significant milestone for Univa Health. Their funding will accelerate the development of an AI-enhanced ecosystem for treating eating disorders.
Rich Andrews and Jose Santos, leveraging their extensive healthcare backgrounds, are poised to lead this charge, integrating technology with compassion-driven care.
As Univa advances, its potential to reshape how eating disorders are understood and treated stands to benefit countless patients worldwide.
A Hopeful Outlook
Univa Health is set to pioneer new methodologies in the treatment of eating disorders. Their innovative approach promises to provide much-needed relief for patients and their families, addressing a critical gap in current healthcare services.
The journey ahead for Univa Health is promising, as their AI-powered solutions prepare to tackle the complex challenge of eating disorders. With strategic support and a robust platform, they are well-positioned to make a substantial impact in the healthtech sector.
